Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a talking therapy ease persistent concussion symptoms?

NCT ID NCT04614922

Terminated Symptom relief Sponsor: St. Olavs Hospital Source: ClinicalTrials.gov ↗

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study tests whether a group-based therapy called Acceptance and Commitment Therapy (ACT) can help people with ongoing symptoms after a concussion, such as headaches and trouble thinking. Participants who have had symptoms for more than six months will attend seven group sessions over several weeks. The goal is to see if ACT improves daily function and reduces symptom burden compared to usual care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Acceptance and Commitment Therapy (ACT) — a behavioral therapy that helps people accept difficult thoughts and feelings while committing to value-driven actions
What this could lead to
If effective, ACT could offer a non-drug way to help people with long-lasting concussion symptoms feel better and return to work or school.
What could go wrong
This is a small, early-stage trial with only 48 participants, so results may not apply to everyone. The therapy is time-intensive and requires active participation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST-CONCUSSION SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Post-Concussion Syndrome Post-Traumatic Headache

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POST-CONCUSSION SYNDROME POST-TRAUMATIC HEADACHE

Contacts and locations

Locations

  • St Olavs Hospital Clinic of Physical Medicine and Rehabilitation

    Trondheim, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.